It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 | Mumbai, Maharashtra, India | ActiveKaivan Pharma Private Limited, a active private limited company, was established on 14 February 2015 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51909MH2015PTC261861. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jalak Rushbha Mukati (Director), Kaivan Umesh Chitroda (Additional Director). Past directors included Jalak Chitroda, Parul Chitroda Umesh, Kaivan Umesh Chitroda. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 134 Meghal Service Ind Estate Devidayal Road, Mulund Westq, Mumbai, Maharashtra, 400080.
U51909MH2015PTC261861
261861
14 February 2015
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kaivan Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jalak Rushbha Mukati | Director | 14 Feb 2015 | Current |
| Kaivan Umesh Chitroda | Additional Director | 05 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 08 Jan 2018 | Past |
| Pramod Abcsdd | Director | 25 Apr 2017 | Past |
| Pramod Abcsdd | Additional Director | 11 Feb 2020 | Past |
| Pramod Abcsdd | Additional Director | 08 Jan 2018 | Past |
| Pramod Abcsdd | Additional Director | 11 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kaivan Pharma Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 53.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Kaivan Pharma had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kaivan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kaivan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaivan Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kaivan Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.
The activity Kaivan Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was completed.
Progress on Kaivan Umesh Chitroda was appointed as a Additional Director was appointed as a Additional Director on 05 Jan 2018 & has been associated with this company since 7 years 10 months . was documented.
Jalak Rushbha Mukati was appointed as a Director was appointed as a Director on 14 Feb 2015 & has been associated with this company since 10 years 9 months . was recorded as a recent event.
The activity Kaivan Pharma Private Limited was registered on 14 Feb 2015 with Roc Mumbai & aged 10 years 9 months as per MCA records. was completed.
The CIN of Kaivan Pharma Private Limited is U51909MH2015PTC261861.
Kaivan Pharma Private Limited is headquartered at 134 Meghal Service Ind Estate Devidayal Road, Mulund Westq, Mumbai, Maharashtra, 400080.
Kaivan Pharma Private Limited was incorporated on 14 February 2015.
The current directors of Kaivan Pharma Private Limited are
The primary industry of Kaivan Pharma Private Limited is Pharma.
Kaivan Pharma Private Limited is unlisted.
The authorized capital of Kaivan Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Kaivan Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX